DEK-targeting aptamer DTA-64 attenuates bronchial EMT-mediated airway remodelling by suppressing TGF-β1/Smad, MAPK and PI3K signalling pathway in asthma.
DEK-targeting aptamer DTA-64 attenuates bronchial EMT-mediated airway remodelling by suppressing TGF-β1/Smad, MAPK and PI3K signalling pathway in asthma.
复制标题
DEK 靶向适体 DTA-64 通过抑制哮喘中 TGF-β 1/Smad、MAPK 和 PI3K 信号通路来减弱支气管 EMT 介导的气道重塑
DOI:
10.1111/jcmm.15942
复制
发表时间:
2020-12
影响因子:
5.3
通讯作者:
Yan G
中科院分区:
文献类型:
--
作者:
Song Y;Wang Z;Jiang J;Piao Y;Li L;Xu C;Piao H;Li L;Yan G
This study is to investigate the inhibitory effects and mechanisms of DEK‐targeting aptamer (DTA‐64) on epithelial mesenchymaltransition (EMT)‐mediated airway remodelling in mice and human bronchial epithelial cell line BEAS‐2B. In the ovalbumin (OVA)‐induced asthmatic mice, DTA‐64 significantly reduced the infiltration of eosinophils and neutrophils in lung tissue, attenuated the airway resistance and the proliferation of goblet cells. In addition, DTA‐64 reduced collagen deposition, transforming growth factor 1 (TGF‐β1) level in BALF and IgE levels in serum, balanced Th1/Th2/Th17 ratio, and decreased mesenchymal proteins (vimentin and α‐SMA), as well as weekend matrix metalloproteinases (MMP‐2 and MMP‐9) and NF‐κB p65 activity. In the in vitro experiments, we used TGF‐β1 to induce EMT in the human epithelial cell line BEAS‐2B. DEK overexpression (ovDEK) or silencing (shDEK) up‐regulated or down‐regulated TGF‐β1 expression, respectively, on the contrary, TGF‐β1 exposure had no effect on DEK expression. Furthermore, ovDEK and TGF‐β1 synergistically promoted EMT, whereas shDEK significantly reduced mesenchymal markers and increased epithelial markers, thus inhibiting EMT. Additionally, shDEK inhibited key proteins in TGF‐β1‐mediated signalling pathways, including Smad2/3, Smad4, p38 MAPK, ERK1/2, JNK and PI3K/AKT/mTOR. In conclusion, the effects of DTA‐64 against EMT of asthmatic mice and BEAS‐2B might partially be achieved through suppressing TGF‐β1/Smad, MAPK and PI3K signalling pathways. DTA‐64 may be a new therapeutic option for the management of airway remodelling in asthma patients.
登录
查看更多内容
DOI:
10.1038/labinvest.2016.109
发表时间:
2016-12
期刊:
Laboratory investigation; a journal of technical methods and pathology
影响因子:
--
作者:
通讯作者:
--
影响因子:
7.7
作者:
Chen, Hai-hua;Zhou, Xian-long;Yang, Jiong
通讯作者:
Yang, Jiong
影响因子:
16.6
作者:
Campa, Carlo C.;Silva, Rangel L.;Hirsch, Emilio
通讯作者:
Hirsch, Emilio
影响因子:
5.6
作者:
Lee, Kam-Fai;Tsai, Ming-Ming;Lin, Kwang-Huei
通讯作者:
Lin, Kwang-Huei
影响因子:
16.6
作者:
Mor-Vaknin N;Saha A;Legendre M;Carmona-Rivera C;Amin MA;Rabquer BJ;Gonzales-Hernandez MJ;Jorns J;Mohan S;Yalavarthi S;Pai DA;Angevine K;Almburg SJ;Knight JS;Adams BS;Koch AE;Fox DA;Engelke DR;Kaplan MJ;Markovitz DM
通讯作者:
Markovitz DM